“The whole package deal”: experiences of overweight/obese women living with polycystic ovary syndrome

被引:0
|
作者
Carolyn Ee
Caroline Smith
Lisa Moran
Freya MacMillan
Michael Costello
Brandi Baylock
Helena Teede
机构
[1] NICM Health Research Institute,Graduate Research School, and NICM Health Research Institute
[2] Western Sydney University,Monash Centre for Health Research and Implementation
[3] Western Sydney University, MCHRI, School of Public Health and Preventive Medicine
[4] Monash University,School of Health Sciences, and the Translational Health Research Institute
[5] Western Sydney University,School of Women’s and Children’s Health, UNSW
[6] Royal Hospital for Women,Monash Centre for Health Research and Implementation – MCHRI, School of Public Health and Preventive Medicine
[7] Western Sydney University,undefined
[8] Monash University,undefined
来源
BMC Women's Health | / 20卷
关键词
Polycystic ovary syndrome; Obesity; Weight; Psychological;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Subclinical inflammation in obese women with polycystic ovary syndrome
    Elkholi, Dina
    Hammoudah, Sahar
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2012, 17 (03) : 195 - 202
  • [32] Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome
    Moran, L. J.
    Teede, H. J.
    Noakes, M.
    Clifton, P. M.
    Norman, R. J.
    Wittert, G. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (11) : 1004 - 1010
  • [33] Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome
    L. J. Moran
    H. J. Teede
    M. Noakes
    P. M. Clifton
    R. J. Norman
    G. A. Wittert
    Journal of Endocrinological Investigation, 2013, 36 : 1004 - 1010
  • [34] Advanced therapy of overweight or obese polycystic ovary syndrome: a prospective study
    Min Min
    Xiangyan Ruan
    Alfred OMueck
    Global Health Journal, 2022, (02) : 75 - 79
  • [35] Eating disorder risk in overweight and obese polycystic ovary syndrome patients
    Rodriguez-Paris, D.
    Banaszewska, B.
    Remlinger-Molenda, A.
    EUROPEAN PSYCHIATRY, 2019, 56 : S354 - S355
  • [36] Metabolic abnormalities in polycystic ovary syndrome women: obese and non obese
    Maltoni Romano, Lucas Gabriel
    Bedoschi, Giuliano
    Sanches Melo, Anderson
    Oliveira de Albuquerque, Felipe
    Japur de Sa Rosa e Silva, Ana Carolina
    Ferriani, Rui Alberto
    Navarro, Paula Andrea
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2011, 33 (06): : 310 - 316
  • [37] Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
    Rui-Lin Ma
    Yan Deng
    Yan-Fang Wang
    Shi-Yang Zhu
    Xue-Song Ding
    Ai-Jun Sun
    中华医学杂志英文版, 2021, 134 (23) : 2882 - 2889
  • [38] GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome
    Orio, F
    Palomba, S
    Colao, A
    Russo, T
    Dentico, C
    Tauchmanovà, L
    Savastano, S
    Nappi, C
    Sultan, C
    Zullo, F
    Lombardi, G
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (02) : 117 - 122
  • [39] GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome
    Francesco Orio
    S. Palomba
    A. Colao
    T. Russo
    C. Dentico
    L. Tauchmanovà
    S. Savastano
    C. Nappi
    C. Sultan
    F. Zullo
    G. Lombardi
    Journal of Endocrinological Investigation, 2003, 26 : 117 - 122
  • [40] Ovulatory status of overweight women without Polycystic Ovary Syndrome
    Sasaki, Reinaldo S. A.
    Approbato, Mario S.
    Maia, Monica C. S.
    Fleury e Ferreira, Eliamar A. B.
    Zanluchi, Neuma
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2019, 23 (01): : 2 - 6